Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Crinetics Pharmaceuticals (CRNX) Preferred Shares Issued (2017 - 2018)

Crinetics Pharmaceuticals (CRNX) has 2 years of Preferred Shares Issued data on record, last reported at $9000.0 in Q4 2018.

  • For Q4 2018, Preferred Shares Issued fell 99.88% year-over-year to $9000.0; the TTM value through Dec 2018 reached $63.3 million, changed N/A, while the annual FY2018 figure was $63.3 million, 428.66% up from the prior year.
  • Preferred Shares Issued reached $9000.0 in Q4 2018 per CRNX's latest filing, up from -$234000.0 in the prior quarter.
  • Across five years, Preferred Shares Issued topped out at $63.5 million in Q1 2018 and bottomed at -$234000.0 in Q2 2018.